Contrast and virtual colonoscopy accessory developer E-Z-EM reported net sales of $33.4 million in its first quarter of fiscal 2007 (end-September 2), a 2.8% slump compared with the prior year's first-quarter net revenues of $34.4 million.
The Lake Success, NY-based firm stated that net sales in the previous year's first quarter benefited from an additional selling week compared with the fiscal 2007 first quarter, as well as from approximately $1.6 million in backlog sales associated with the voluntary recall of certain liquid barium products by the Mallinckrodt business unit of Tyco Healthcare, which affected CT imaging and x-ray fluoroscopy products.
Net earnings for the fiscal 2007 first quarter were $1.6 million, also down from net earnings for the fiscal 2006 first quarter of $2.6 million. E-Z-EM said that its first-quarter fiscal 2007 results reflect a loss from discontinued operations of $200,000 associated with the closing of its Japanese subsidiary.
The company affirmed its financial guidance for fiscal year 2007 with net sales of at least $147 million and net earnings of at least $7.4 million.
By AuntMinnie.com staff writers
October 11, 2006
Related Reading
E-Z-EM signs Amerinet, September 11, 2006
E-Z-EM notches record fiscal year, August 11, 2006
E-Z-EM launches new insufflator, May 22, 2006
E-Z-EM delivers upbeat Q3, April 12, 2006
E-Z-EM posts strong Q2, January 11, 2006
Copyright © 2006 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)